BML Investment Partners, L.P.

Holdings History for Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Symbol: ACRS on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value
Latest Disclosed Shares Owned: 14,250,000 shares
Security Ownership %: 12%

BML Investment Partners, L.P. ownership in Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS)

09 Feb 2026 - BML Investment Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 14,250,000 shares of Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS). This represents 12% ownership of the company. In their previous filing dated 13 Feb 2025, BML Investment Partners, L.P. had reported owning 14,250,000 shares, indicating a new holding.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BML Investment Partners, L.P.	12%	-11%	$37,620,000	14,250,000	0		$2.64	13G/A	31 Dec 2025	09 Feb 2026, 13:42
BML Investment Partners, L.P.	13%		$21,802,500	14,250,000			$1.53	13G/A	31 Dec 2024	13 Feb 2025, 14:26